Krogvold, Lars
Oslo University Hospital
5 papers on CoChatORCID 0000-0002-1057-7095
Most cited papers
- Verified
Detection of a Low-Grade Enteroviral Infection in the Islets of Langerhans of Living Patients Newly Diagnosed With Type 1 Diabetes
Krogvold, L., Edwin, B., Buanes, T., Frisk, G., Skog, O., Anagandula, M., Korsgren, O., Undlien, D., Eike, M. C., Richardson, S. J., et al. (2015) · Diabetes
Diabetes and associated disordersViral Infections and Immunology Research
Cited by 314
- Verified
Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
Richardson, S. J., Rodriguez-Calvo, T., Gerling, I. C., Mathews, C. E., Kaddis, J. S., Russell, M. A., Zeissler, M., Leete, P., Krogvold, L., Dahl-Jørgensen, K., et al. (2016) · Diabetologia
Diabetes and associated disordersPancreatic function and diabetes
Cited by 298
- Verified
Demonstration of Tissue Resident Memory CD8 T Cells in Insulitic Lesions in Adult Patients with Recent-Onset Type 1 Diabetes
Kuric, E., Seiron, P., Krogvold, L., Edwin, B., Buanes, T., Hanssen, K. F., Skog, O., Dahl-Jørgensen, K., & Korsgren, O. (2017) · The American Journal of Pathology
Diabetes and associated disordersT-cell and B-cell Immunology
Cited by 80
- Verified
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial
Krogvold, L., Mynarek, I. M., Ponzi, E., Mørk, F. B., Hessel, T. W., Roald, T., Lindblom, N., Westman, J., Barker, P., Hyöty, H., et al. (2023) · Nature Medicine
Diabetes and associated disordersDiabetes Management and Research
Cited by 55
- Verified
Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial
Mynarek, I. M., Krogvold, L., Mørk, F. B., Lawaetz, T. W. H., Roald, T., Fagerland, M. W., Lindblom, N., Westman, J., Barker, P., Hyöty, H., et al. (2025) · Diabetes Care
Diabetes and associated disordersDiabetes Management and Research
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free